131 related articles for article (PubMed ID: 25503105)
21. Non-surgical interventions for acute internal hordeolum.
Lindsley K; Nichols JJ; Dickersin K
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD007742. PubMed ID: 28068454
[TBL] [Abstract][Full Text] [Related]
22. Interventions for basal cell carcinoma of the skin.
Bath-Hextall FJ; Perkins W; Bong J; Williams HC
Cochrane Database Syst Rev; 2007 Jan; (1):CD003412. PubMed ID: 17253489
[TBL] [Abstract][Full Text] [Related]
23. A review of the evidence for Mohs micrographic surgery. Part 2: basal cell carcinoma.
Brown AC; Brindley L; Hunt WTN; Earp EM; Veitch D; Mortimer NJ; Salmon PJM; Wernham A
Clin Exp Dermatol; 2022 Oct; 47(10):1794-1804. PubMed ID: 35596540
[TBL] [Abstract][Full Text] [Related]
24. Recurrence rates following surgical excision of periocular basal cell carcinomas: systematic review and meta-analysis.
Phan K; Oh LJ; Goyal S; Rutherford T; Yazdabadi A
J Dermatolog Treat; 2020 Sep; 31(6):597-601. PubMed ID: 31769708
[No Abstract] [Full Text] [Related]
25. Management of periocular keratinocyte carcinomas with Mohs micrographic surgery and predictors of complex reconstruction: a retrospective study.
Peirano D; Vargas S; Hidalgo L; Donoso F; Abusleme E; Sanhueza F; Cárdenas C; Droppelmann K; Castro JC; Uribe P; Zoroquiain P; Navarrete-Dechent C
An Bras Dermatol; 2024; 99(2):202-209. PubMed ID: 37989688
[TBL] [Abstract][Full Text] [Related]
26. Mohs Micrographic Surgery Versus Standard Excision for Basal Cell Carcinoma in the Head and Neck: Systematic Review and Meta-Analysis.
Alsaif A; Hayre A; Karam M; Rahman S; Abdul Z; Matteucci P
Cureus; 2021 Nov; 13(11):e19981. PubMed ID: 34984139
[TBL] [Abstract][Full Text] [Related]
27. Predictors for margin of resection >4 mm in the management of periocular basal cell carcinoma.
Almousa R
Korean J Ophthalmol; 2021 Oct; 35(5):391-396. PubMed ID: 34344136
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologic and Nonpharmacologic Interventions for Perioperative Anxiety in Patients Undergoing Mohs Micrographic Surgery: A Systematic Review.
Wan AY; Biro M; Scott JF
Dermatol Surg; 2020 Mar; 46(3):299-304. PubMed ID: 31453905
[TBL] [Abstract][Full Text] [Related]
29. Dermoscopy-guided Mohs micrographic surgery in post-laser basal cell carcinomas: is dermoscopy helpful for demarcation of the surgical margin?
Shin K; Kim HJ; Ko HC; Kim BS; Kim MB; Kim HS
J Dermatolog Treat; 2022 Feb; 33(1):433-436. PubMed ID: 32345116
[TBL] [Abstract][Full Text] [Related]
30. Willingness to Pay for Surgical Treatments for Basal Cell Carcinoma: A Population-Based Cross-Sectional Study.
Kantor J
Dermatol Surg; 2021 Apr; 47(4):467-472. PubMed ID: 33625136
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of micrographic surgery versus conventional excision in reducing recurrence for basal cell carcinoma and squamous cell carcinoma: A systematic review and meta-analysis.
Lacerda PN; Lange EP; Luna NM; Miot HA; Abbade LPF
J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):1058-1069. PubMed ID: 38116955
[TBL] [Abstract][Full Text] [Related]
32. A critical re-evaluation of Mohs micrographic surgery for a facial basal cell carcinoma in older adults: Should we waive this treatment in certain patients?
Van Coile L; Brochez L; Verhaeghe E; Boone B; Meertens A; Ongenae K; Hoorens I
J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1792-1798. PubMed ID: 37147863
[TBL] [Abstract][Full Text] [Related]
33. Reported Outcome Measures in Mohs Micrographic Surgery in Studies With Defined Techniques for Embedding and Processing of Tissue: A Systematic Review.
Govas P; Ha MV; Wessel CB; Hurst A; Gordon BR; Carroll BT
Dermatol Surg; 2023 Dec; 49(12):1116-1121. PubMed ID: 37962132
[TBL] [Abstract][Full Text] [Related]
34. Interventions for basal cell carcinoma: abridged Cochrane systematic review and GRADE assessments.
Thomson J; Hogan S; Leonardi-Bee J; Williams HC; Bath-Hextall FJ
Br J Dermatol; 2021 Sep; 185(3):499-511. PubMed ID: 33448328
[TBL] [Abstract][Full Text] [Related]
35. A review of Mohs micrographic surgery for skin cancer. Part 3: Squamous cell carcinoma.
Hunt WTN; Earp E; Brown AC; Veitch D; Wernham AGH
Clin Exp Dermatol; 2022 Oct; 47(10):1765-1773. PubMed ID: 35315541
[TBL] [Abstract][Full Text] [Related]
36. Does the inclusion of a cost attribute result in different preferences for the surgical treatment of primary basal cell carcinoma?: a comparison of two discrete-choice experiments.
Essers BA; van Helvoort-Postulart D; Prins MH; Neumann M; Dirksen CD
Pharmacoeconomics; 2010; 28(6):507-20. PubMed ID: 20387912
[TBL] [Abstract][Full Text] [Related]
37. Recurrence rate of basal cell carcinoma among different micrographic surgery techniques: systematic review with meta-analysis.
Lacerda PN; Lange EP; Luna NM; Miot HA; Nogueira VSN; Abbade LPF
J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1178-1190. PubMed ID: 35274381
[TBL] [Abstract][Full Text] [Related]
38. Traditional versus streamlined management of basal cell carcinoma (BCC): A cost analysis.
Wu X; Elkin EB; Jason Chen CS; Marghoob A
J Am Acad Dermatol; 2015 Nov; 73(5):791-8. PubMed ID: 26341142
[TBL] [Abstract][Full Text] [Related]
39. Skin substitutes for the management of mohs micrographic surgery wounds: a systematic review.
Lu KW; Khachemoune A
Arch Dermatol Res; 2023 Jan; 315(1):17-31. PubMed ID: 35169876
[TBL] [Abstract][Full Text] [Related]
40. Consistency in Distribution of Facial Skin Cancers Treated With Mohs Micrographic Surgery.
Horeczko J; Hendi A
J Drugs Dermatol; 2022 May; 21(5):506-509. PubMed ID: 35533023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
